Phase: Phase IVType: TreatmentStatus: ClosedAge: 18 and overSponsor: Pharmaceutical / IndustryProtocol IDs: C25007, 2013-000232-10, U1111-1154-2250, NMRR-13-1246-18099, REec-2014-0619, NCT01990534Phase: Phase II, Phase IType: TreatmentStatus: ClosedAge: 18 and overSponsor: Pharmaceutical / IndustryProtocol IDs: SGN35-016, NCT01874054Phase: Phase IIType: TreatmentStatus: CompletedAge: 12 to 120Sponsor: Pharmaceutical / IndustryProtocol IDs: SGN35-006, 2010-019932-11, NCT00947856Phase: Phase IIType: Biomarker/Laboratory analysis, TreatmentStatus: ClosedAge: 6 and overSponsor: Pharmaceutical / IndustryProtocol IDs: SGN35-012, NCT01421667Phase: Phase IIType: Biomarker/Laboratory analysis, TreatmentStatus: CompletedAge: 6 and overSponsor: Pharmaceutical / IndustryProtocol IDs: SGN35-013, NCT01461538Phase: Phase IIType: TreatmentStatus: ClosedAge: 12 to 72Sponsor: OtherProtocol IDs: 11-142, NCT01508312Phase: Phase IIType: TreatmentStatus: ClosedAge: 18 to 60Sponsor: OtherProtocol IDs: Targeted BEACOPP, NCT01569204Phase: Phase IType: Biomarker/Laboratory analysis, TreatmentStatus: CompletedAge: 18 and overSponsor: Pharmaceutical / IndustryProtocol IDs: SGN35-008, NCT01026415Phase: Phase IType: Biomarker/Laboratory analysis, TreatmentStatus: Temporarily closedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2013-01275, E4412, U10CA180820, U10CA021115, NCT01896999Phase: Phase IType: Biomarker/Laboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2013-01273, 13-044, 9467, P30CA008748, U01CA069856, NCT01902160Phase: Phase IType: Biomarker/Laboratory analysis, TreatmentStatus: ClosedAge: 18 to 75Sponsor: Pharmaceutical / IndustryProtocol IDs: C25005, 2013-000193-29, NCT01950364Phase: No phase specifiedType: TreatmentStatus: ClosedAge: 18 and overSponsor: Pharmaceutical / IndustryProtocol IDs: LYMNHL0089, SU-06212011-7946, NCT01396070
